BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37897199)

  • 1. Heterogeneity of cancer stem cell-related marker expression is associated with three-dimensional structures in malignant pleural effusion produced by lung adenocarcinoma.
    Lin YY; Lin YS; Liang CW
    Cytopathology; 2024 Jan; 35(1):105-112. PubMed ID: 37897199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.
    Chen SF; Lin YS; Jao SW; Chang YC; Liu CL; Lin YJ; Nieh S
    PLoS One; 2013; 8(5):e54659. PubMed ID: 23658677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMT markers in lung adenocarcinoma pleural effusion spheroid cells.
    Giarnieri E; De Vitis C; Noto A; Roscilli G; Salerno G; Mariotta S; Ricci A; Bruno P; Russo G; Laurenzi A; Giovagnoli MR; Ciliberto G; Mancini R
    J Cell Physiol; 2013 Aug; 228(8):1720-6. PubMed ID: 23255165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of telomere length in cells from pleural effusion: Asbestos exposure causes telomere shortening in pleural mesothelial cells.
    Aida S; Aida J; Naoi M; Kato M; Tsuura Y; Natsume I; Takubo K
    Pathol Int; 2018 Sep; 68(9):503-508. PubMed ID: 30098092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Single-cell pattern" of adenocarcinoma cells in effusion cytology: Morphologic challenges of lung cancer.
    Guleria P; Barwad A; Malik PS; Madan K; Jain D
    Diagn Cytopathol; 2021 Jan; 49(1):77-82. PubMed ID: 32818307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
    Watabe S; Kikuchi Y; Morita S; Komura D; Numakura S; Kumagai-Togashi A; Watanabe M; Matsutani N; Kawamura M; Yasuda M; Uozaki H
    Cancer Med; 2020 Apr; 9(8):2879-2890. PubMed ID: 32091667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
    Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A
    Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
    Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
    Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.
    Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S
    Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
    Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
    Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples.
    Guan Y; Wang ZJ; Wang LQ; Hua DF; Liu J
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical expression of a panel of markers in pleural effusions from patients with primary lung adenocarcinoma.
    Chaini E; Athanassiadou AM; Vassias A; Tsipis A; Gonidi M; Hainis KD; Charpidou A; Athanassiadou P
    Pathol Res Pract; 2017 May; 213(5):502-508. PubMed ID: 28285961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of MOC-31 and calretinin in pleural fluid of patients with lung cancer.
    Lv M; Leng JH; Hao YY; Sun Y; Cha N; Wu GP
    Diagn Cytopathol; 2015 Jul; 43(7):527-31. PubMed ID: 25346242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes].
    Ma H; Jia J; Guo H; Zhao H; Wang C; Zhao L; Sun Y; Li W; Zhang Z
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):150-155. PubMed ID: 32209183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.
    Mancini R; Giarnieri E; De Vitis C; Malanga D; Roscilli G; Noto A; Marra E; Laudanna C; Zoppoli P; De Luca P; Affuso A; Ruco L; Di Napoli A; Mesiti G; Aurisicchio L; Ricci A; Mariotta S; Pisani L; Andreetti C; Viglietto G; Rendina EA; Giovagnoli MR; Ciliberto G
    PLoS One; 2011; 6(7):e21320. PubMed ID: 21789168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
    Huang L
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion.
    Yan J; Wei Q; Jian W; Liu J; Tang H; Ge J; Zhou J; Zhao T
    Int J Clin Exp Pathol; 2014; 7(9):5810-8. PubMed ID: 25337222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy.
    Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D
    Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.